课题基金 / 基金详情

Cellular signaling and Trafficking of APP Family Members

Cellular signaling and Trafficking of APP Family Members
APP 家族成员的蜂窝信号传导和贩运
批准号:
6734633
负责人:
LUCIANO D'ADAMIO
金额:
$47.59万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-15 至 2008-03-31

项目摘要

项目成果

LUCIANO D'ADAMIO的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供): 家族性阿尔茨海默病基因产物β淀粉样蛋白(ABeta)前体蛋白(APP)被加工产生ABeta,ABeta被认为是阿尔茨海默病的主要罪魁祸首之一。APP首先由α-或β-分泌酶在细胞外加工,分别产生C83或C99膜系链片段,然后由跨膜结构域中的γ-分泌酶加工。通过β-和γ-分泌酶的加工导致产生ABeta以及来源于APP的极端羧基末端的AID(APP胞内结构域)。AID最初显示降低细胞凋亡阈值,最近已显示调节基因表达和细胞钙稳态。APP是包括APP样分子APLP 1和APLP 2的基因家族的成员。使用基因敲除小鼠的研究表明,APP,APLP 1和APLP 2具有部分冗余功能以及独特的作用。由于APP通过释放生物活性AID肽来发出信号,因此APLP 1和APLP 2也可能由于g-分泌酶的加工而释放生物活性APP样细胞内结构域ALID。目前的建议的主要目标是表征由APP,APLP 1和APLP 2加工调节的信号通路。这些研究可以揭示每个APP家族成员共同或特异性和独特的信号通路。在这种情况下,我们还将研究APP家族成员在初级神经元中的贩运。APP在神经元中的转运可能与APP在神经细胞中的生物学功能密切相关,并可能调节神经突起的生长。这些研究可能阐明APP家族成员的生物学作用,并在开发用于治疗和/或预防阿尔茨海默病的新化合物方面具有重要的实际应用。
英文摘要
DESCRIPTION (provided by applicant): The familial Alzheimer's disease gene product amyloid Beta (ABeta) precursor protein (APP) is processed to generate ABeta which is considered to be one of the major culprits of Alzheimer's disease. APP is first processed extracellularly by the alpha- or Beta-secretase creating either a C83 or C99 membrane tether fragment, respectively, and then by the gamma-secretase in the transmembrane domain. Processing by the Beta- and gamma-secretase leads to production of ABeta as well as AID (APP Intracellular Domain) which is derived from APP's extreme carboxy terminus. AID was originally shown to lower the cellular threshold to apoptosis and more recently has been shown to modulate gene expression and cellular calcium homeostasis. APP is a member of a gene family that includes the APP like molecules APLP1 and APLP2. Studies using knock out mice have demonstrated that APP, APLP1 and APLP2 have partially redundant functions as well as unique roles. Since APP signals by releasing the biologically active AID peptide, it is possible that APLP1 and APLP2 also release biologically active APP Like Intracellular Domains ALIDs due to processing by the g-secretase. The major goals of the current proposal are to characterize the signaling pathways regulated by APP, APLP1 and APLP2 processing. These studies could unveil the signaling pathways that are either common or specific and unique to each APP family member. In this context, we will also study the trafficking of APP family members in primary neurons. The transport of APP in neurons may be of great relevance to the biological function of APP in neuronal ceils and may regulate neurite growth. These studies may clarify the biological role of APP family members and have important practical applications in the development of new compounds for the cure and or prevention of Alzheimer's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery of therapeutic nanobodies targeting brain TNF-α for the treatment of Alzheimer Disease
  • 批准号:
    10697218
  • 项目类别:
  • 资助金额:
    $49.98万
  • 财政年份:
    2023
  • 负责人:
    LUCIANO D'ADAMIO
  • 依托单位:
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
  • 批准号:
    10459558
  • 项目类别:
  • 资助金额:
    $78.25万
  • 财政年份:
    2021
  • 负责人:
    LUCIANO D'ADAMIO
  • 依托单位:
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
  • 批准号:
    10273589
  • 项目类别:
  • 资助金额:
    $78.25万
  • 财政年份:
    2021
  • 负责人:
    LUCIANO D'ADAMIO
  • 依托单位:
Trem2-mediated microglia-neuronal axis in Alzheimer disease pathogenesis
海外基金